Compile Data Set for Download or QSAR
Report error Found 88 Enz. Inhib. hit(s) with all data for entry = 12708
TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721467(US12227517, Example 73)
Affinity DataIC50: 0.700nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721474(US12227517, Example 80)
Affinity DataIC50: 0.700nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721471(US12227517, Example 77)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721429(US12227517, Example 35)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721453(US12227517, Example 59)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721217(US12227517, Example 1)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721480(US12227517, Example 86)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721432(US12227517, Example 38)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721476(US12227517, Example 82)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721454(US12227517, Example 60)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721455(US12227517, Example 61)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721320(US12227517, Example 6)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721477(US12227517, Example 83)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721462(US12227517, Example 68)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721427(US12227517, Example 33)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721472(US12227517, Example 78)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721416(US12227517, Example 22)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721470(US12227517, Example 76)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721478(US12227517, Example 84)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721415(US12227517, Example 21)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721469(US12227517, Example 75)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721433(US12227517, Example 39)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721464(US12227517, Example 70)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721403(US12227517, Example 15)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721442(US12227517, Example 48)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721388(US12227517, Example 10)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721386(US12227517, Example 9)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721383(US12227517, Example 8)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721443(US12227517, Example 49)
Affinity DataIC50: 10nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721456(US12227517, Example 62)
Affinity DataIC50: 10nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721417(US12227517, Example 23)
Affinity DataIC50: 10nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721435(US12227517, Example 41)
Affinity DataIC50: 11nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721418(US12227517, Example 24)
Affinity DataIC50: 11nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721459(US12227517, Example 65)
Affinity DataIC50: 12nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721461(US12227517, Example 67)
Affinity DataIC50: 12nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721428(US12227517, Example 34)
Affinity DataIC50: 12nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721405(US12227517, Example 17)
Affinity DataIC50: 13nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721399(US12227517, Example 13)
Affinity DataIC50: 13nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721430(US12227517, Example 36)
Affinity DataIC50: 13nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721401(US12227517, Example 14)
Affinity DataIC50: 13nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721463(US12227517, Example 69)
Affinity DataIC50: 13nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721409(US12227517, Example 19)
Affinity DataIC50: 15nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721479(US12227517, Example 85)
Affinity DataIC50: 15nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721445(US12227517, Example 51)
Affinity DataIC50: 16nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721395(US12227517, Example 12)
Affinity DataIC50: 17nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721448(US12227517, Example 54)
Affinity DataIC50: 17nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721466(US12227517, Example 72)
Affinity DataIC50: 18nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721438(US12227517, Example 44)
Affinity DataIC50: 19nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721407(US12227517, Example 18)
Affinity DataIC50: 19nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetDiacylglycerol kinase epsilon(Human)
Astellas Pharma

US Patent
LigandPNGBDBM721392(US12227517, Example 11)
Affinity DataIC50: 19nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

Displayed 1 to 50 (of 88 total ) | Next | Last >>
Jump to: